posttransplant tacrolimus-induced diabetic ketoacidosis: review of the literature
Clicks: 187
ID: 131605
2018
Diabetic ketoacidosis (DKA) in patients receiving tacrolimus as part of their immunosuppressive regimen is a rarely reported adverse event. We report a patient with autosomal dominant polycystic kidney disease (ADPKD) and no known history of diabetes mellitus who presented with DKA, 3 months after kidney transplantation.
| Reference Key |
ammari2018caseposttransplant
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Zaid Ammari;Stella C. Pak;Mohammed Ruzieh;Osama Dasa;Abhinav Tiwari;Juan C. Jaume;Maria A. Alfonso-Jaume |
| Journal | chemosensors |
| Year | 2018 |
| DOI | 10.1155/2018/4606491 |
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.